Win poor health biotech shares ever recuperate? How effectively do Covid-19 vaccines work for teenagers? And might something cease the amyloid speculation?
We cowl all that and extra this week on “The Readout LOUD,” STAT’s biotech podcast. Longtime biotech investor Les Funtleyder joins us to elucidate why the current rate of interest hike is dangerous for biotech and simply what it is going to take for the trade to get out of its stoop. Then, vaccinologist and FDA adviser Paul Offit calls in to speak in regards to the impending authorization of Covid-19 vaccines for younger kids and what it means for the way forward for the pandemic. We additionally clarify the newest disappointing medical trial in Alzheimer’s illness and a few perplexing knowledge on Pfizer’s Covid-19 antiviral.
For extra on what we cowl, right here’s more on the FDA’s vaccine deliberations; right here’s the news in Alzheimer’s; right here’s the story on Paxlovid; right here’s where you can find episodes of Color Code; right here’s where you can subscribe to the First Opinion Podcast; and right here’s our complete coverage of the Covid-19 pandemic.
And when you have any suggestions for us — subjects to cowl, friends to ask, vocal tics to stop — you’ll be able to e mail [email protected].